Evidence map›Paper›PMID 28707272›Full record

ArticleArchives of virology2017

First molecular characterization of canine parvovirus strains in Sardinia, Italy.

S Dei Giudici, T Cubeddu, A Giagu, G Sanna, S Rocca, A Oggiano

Open access · hybridAbstract read
In one paragraph

Article in Archives of virology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.1field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Phylogenetic analysis of canine parvovirus isolates from west Mediterranean region of Türkiye.Veterinary research forum : an international quarterly journal · 2023
    Article
  5. Article
  6. Molecular characterization ofFrontiers in veterinary science · 2022
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

S Dei GiudiciIstituto Zooprofilattico Sperimentale della Sardegna G. Pegreffi, Via Vienna 2, 07100, Sassari, Italy. silvia.deigiudici@izs-sardegna.it.
T CubedduDipartimento di Medicina Veterinaria, Università di Sassari, Via Vienna 2, 07100, Sassari, Italy. tcubeddu@uniss.it.
A GiaguDipartimento di Medicina Veterinaria, Università di Sassari, Via Vienna 2, 07100, Sassari, Italy.
G SannaIstituto Zooprofilattico Sperimentale della Sardegna G. Pegreffi, Via Vienna 2, 07100, Sassari, Italy.
S RoccaDipartimento di Medicina Veterinaria, Università di Sassari, Via Vienna 2, 07100, Sassari, Italy.
A OggianoIstituto Zooprofilattico Sperimentale della Sardegna G. Pegreffi, Via Vienna 2, 07100, Sassari, Italy.
Istituto Zooprofilattico Sperimentale della Sardegna · ITUniversity of Sassari · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Canine parvovirus type 2 (CPV-2) is responsible of acute hemorrhagic gastroenteritis in young dogs. CPV-2 emerged in 1978 in the USA, but new antigenic types, CPV-2a, 2b and 2c, have completely replaced the original type. In this study, we analyzed 81 animals collected in Sardinia, Italy. The VP2 sequence analysis of 27 positive samples showed that all antigenic CPV-2 types are circulating. CPV-2b seems to be the most widespread variant, followed by CPV-2a. Furthermore, 12 CPV-2b strains displayed further amino acid substitutions and formed a separate cluster in a phylogenetic tree, indicating regional genetic variation.

Indexed as

AnimalsCat DiseasesCatsDog DiseasesDogsItalyParvoviridae InfectionsParvovirus, CaninePhylogenyCanine parvovirus (CPV)Phylogenetic analysisVP2 gene

Identifiers

PMID28707272
PMCPMC5640725
OpenAlexW2735754597

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.